glucagon glp-1 LY3437943, a novel triple glucagon, GIP, and receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism Glucagon-Like Peptide-1 Receptor Agonists–Health Professional

10.1113/jphysiol.2010.204255 31 FinkA

E.QiuY.CoatsJ

En contraparte, en la Diabetes mellitus tipo 2 (DM2) se encuentran alteraciones en la funcin de las incretinas con resistencia a sus efectos, lo que se relaciona con un peor perfil cardiometablico y riesgo cardiovascular

Drugs that attenuate cell death and inflammation or reduce oxidative stress and renal fibrosis were tested

The degree to which autophagy induction leads to observable enhancements in human metabolic health, especially among individuals with T2DM or metabolic syndrome, is still not fully understood [27]

Involvement of chymase-mediated angiotensin II generation in blood pressure regulation